Micheli Francesco 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Aug 17, 2020
Insider Transaction Report
Form 4
Micheli Francesco
10% Owner
Transactions
- Sale
Common stock, par value $0.001 per share
2020-08-14$50.55/sh−54,600$2,760,112→ 5,362,400 total(indirect: See Footnote) - Sale
Common stock, par value $0.001 per share
2020-08-17$50.15/sh−126,888$6,362,913→ 5,235,512 total(indirect: See Footnote) - Sale
Common stock, par value $0.001 per share
2020-08-17$46.75/sh−1,235,512$57,760,186→ 4,000,000 total(indirect: See Footnote) - Sale
Common stock, par value $0.001 per share
2020-08-13$52.60/sh−83,000$4,365,451→ 5,417,000 total(indirect: See Footnote)
Footnotes (2)
- [F1]These shares are held by Genextra S.p.A. Mr. Micheli is the Executive Director and Chairman of the board of Genextra S.p.A. and, in such capacity, Mr. Micheli exercises voting control over the shares of common stock owned by Genextra S.p.A and investment control over such shares as authorized by the board of Genextra S.p.A. Mr. Micheli disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
- [F2]Genextra S.p.A. will apply the proceeds from the sales to pay off outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.